Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tsao

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agentsMuling Mao, Feng Tian, John M Mariadason, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.
Journal of Medicinal Chemistry|April 10, 2009
Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonistsJinlong Jiang, Jaime L Bunda, Geoge A Doss, et al.
Journal of Medicinal Chemistry|July 2, 2013
2-[(3aR,4R,5S,7aS)-5-{(1S)-1-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2H-isoindol-2-yl]-1,3-oxazol-4(5H)-one: a potent human NK1 receptor antagonist with multiple clearance pathwaysAndrew J Kassick, Jinlong Jiang, Jaime Bunda, et al.
Waste Management & Research : the Journal of the International Solid Wastes and Public Cleansing Association, ISWA|October 1, 2010
Effects of spiked metals on the MSW anaerobic digestionH M Lo, C F Chiang, H C Tsao, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agentsMuling Mao, Feng Tian, John M Mariadason, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2007
The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidinePeter Lin, Lehua Chang, Robert J Devita, et al.
Journal of Medicinal Chemistry|April 10, 2009
Potent, brain-penetrant, hydroisoindoline-based human neurokinin-1 receptor antagonistsJinlong Jiang, Jaime L Bunda, Geoge A Doss, et al.
Journal of Medicinal Chemistry|July 2, 2013
2-[(3aR,4R,5S,7aS)-5-{(1S)-1-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxyethoxy}-4-(2-methylphenyl)octahydro-2H-isoindol-2-yl]-1,3-oxazol-4(5H)-one: a potent human NK1 receptor antagonist with multiple clearance pathwaysAndrew J Kassick, Jinlong Jiang, Jaime Bunda, et al.
Waste Management & Research : the Journal of the International Solid Wastes and Public Cleansing Association, ISWA|October 1, 2010
Effects of spiked metals on the MSW anaerobic digestionH M Lo, C F Chiang, H C Tsao, et al.
Pageof 18